NEW YORK--(BUSINESS WIRE)--Bioenvision, Inc. (NasdaqGM:BIVN) today announced MaryJane Rafii, Ph.D. has joined the Company as Vice President, Regulatory Affairs effective October 30th. Dr. Rafii brings to Bioenvision over 12 years of pharmaceutical and biotechnology industry experience. The appointment signals the Company’s focus on expanding the markets for its approved products and developing the product pipeline.
